Cancer News and Research

Latest Cancer News and Research

Vortex Biotech opens new state-of-the-art laboratory at Manchester Science Park

Vortex Biotech Holdings Limited has announced the opening of its advanced laboratory facilities at Manchester Science Park.

27 Jan 2026

Trump policies at odds with emerging understanding of covid’s long-term harm

27 Jan 2026

Doctors increasingly see AI scribes in a positive light. But hiccups persist.

When Jeannine Urban went in for a checkup in November, she had her doctor's full attention.

27 Jan 2026

Reducing alcohol consumption could ease Australia’s cancer burden

National data indicates that lowering alcohol consumption could prevent thousands of cancer deaths, emphasizing the importance of public health interventions.

27 Jan 2026

New prognostic model improves survival prediction for spinal metastasis patients

Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe pain and paralysis, significantly impacting quality of life.

27 Jan 2026

New trial tests strategies to protect heart health during prostate cancer therapy

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.S. News & World Report, has opened a phase 2 clinical trial comparing three different strategies for protecting heart health in prostate cancer patients who receive androgen deprivation therapy (ADT), a potentially lifesaving hormone therapy.

26 Jan 2026

Physical behavior reveals aggressive cancer cells in a simple new approach

New study shows that aggressive cancer cells can be identified in a simple, new way; by how they physically behave, not just by their genes.

26 Jan 2026

Lifetime alcohol consumption associated with higher risk of colorectal cancer

Studies have demonstrated a link between alcohol consumption and an elevated risk of colorectal cancer. New research now reveals that higher lifetime alcohol consumption is also associated with a higher risk,

26 Jan 2026

Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly in regions with high hepatitis B virus prevalence.

24 Jan 2026

Colorblindness linked to delayed bladder cancer detection and higher mortality

Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people to a diagnosis.

24 Jan 2026

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

We knew we had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue.

24 Jan 2026

Unraveling liver injury mechanisms in familial hypobetalipoproteinemia

Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal co-dominant monogenic disorder characterized by lifelong low plasma levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and APOB.

24 Jan 2026

Metabolic reprogramming drives prostate cancer progression and treatment resistance

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy (ADT), the disease often progresses to castration-resistant prostate cancer (CRPC).

24 Jan 2026

New assessment framework improves evaluation of cutaneous chronic graft-versus-host disease

An international task force of medical experts recently proposed major revisions to the way doctors measure treatment success for a common–and often severe–skin complication of stem cell transplantation.

24 Jan 2026

Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and the 5-year survival for advanced/metastatic disease is <10%.

24 Jan 2026

MYC cancer gene suppresses immune alarm signals to protect pancreatic tumors

The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system.

23 Jan 2026

Engineered mesenchymal and endothelial cell layers effectively mimic native lymph nodes

The rising incidence of cancer worldwide has led to an increasing number of surgeries that involve the removal of lymph nodes. Although these procedures play a major role in cancer staging and preventing the spread of malignancies, they sometimes come with severe long-term consequences.

23 Jan 2026

Loss of metabolic control mechanisms promotes uncontrolled cancer cell proliferation

Researchers from the University of Seville have participated in research to identify the molecular details of the regulation of an enzyme essential for sugar metabolism and closely linked to cell proliferation and growth: pyruvate kinase.

23 Jan 2026

Trojan horse immunotherapy opens tumors to immune system attack

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells directly, it targets the cells that protect them.

22 Jan 2026

New partnership aims to expand global access to sickle cell gene therapy

Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children's Hospital today announced a collaboration to provide a sustainable, affordable pathway for patients to access stem cell gene therapies for the treatment of Sickle Cell Disease (SCD).

22 Jan 2026

Cancer News and Research

Latest Cancer News and Research

Vortex Biotech opens new state-of-the-art laboratory at Manchester Science Park

Trump policies at odds with emerging understanding of covid’s long-term harm

Doctors increasingly see AI scribes in a positive light. But hiccups persist.

Reducing alcohol consumption could ease Australia’s cancer burden

New prognostic model improves survival prediction for spinal metastasis patients

New trial tests strategies to protect heart health during prostate cancer therapy

Physical behavior reveals aggressive cancer cells in a simple new approach

Lifetime alcohol consumption associated with higher risk of colorectal cancer

Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Colorblindness linked to delayed bladder cancer detection and higher mortality

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

Unraveling liver injury mechanisms in familial hypobetalipoproteinemia

Metabolic reprogramming drives prostate cancer progression and treatment resistance

New assessment framework improves evaluation of cutaneous chronic graft-versus-host disease

Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer

MYC cancer gene suppresses immune alarm signals to protect pancreatic tumors

Engineered mesenchymal and endothelial cell layers effectively mimic native lymph nodes

Loss of metabolic control mechanisms promotes uncontrolled cancer cell proliferation

Trojan horse immunotherapy opens tumors to immune system attack

New partnership aims to expand global access to sickle cell gene therapy

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in